bone injuries
standard bone autograft
expanded bone marrow MSC
spontaneous bone regeneration
reported bone healing rate
routine clinical treatments
early clinical trials
future of bone regenerative medicin
prospective randomized clinical trials
ORTHOpedic randomized clinical trial
routine clinical application
long bone nonUNIONs Current orthopaedic treatments
autologous ATMP of GMP
Underreported results
ORTHOUNION Project
credibility of RCT results
surgery
alternative treatments
fracture non-unions
previous trials
FP7-Project
REBORNE
absence of early trial confirmation
non-inferiority analysis
Regenerative medicine research
human MSC
gold-standard
prospective RCTs
GMP multicentric production
main aim of ORTHOUNION
personalized medicine supportive instruments
bioceramics
patient selection
monitoring
translation
biomaterial refinement
participating countries
advanced therapy medicinal products
manufacturing capacity
lower costs
general public
innovative strategies
GÃ³mez-Barrena et
disability
quality
GCP
National Competent Authorities
relevant efficacy
health economic evaluation
manuscript
technique
Secondary aims
cell dose
Non-union associates pain
potential benefit
evidence
biological enhancement
ECRIN-ERIC
development